These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20631685)

  • 21. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.
    Franke B; Vasquez AA; Johansson S; Hoogman M; Romanos J; Boreatti-Hümmer A; Heine M; Jacob CP; Lesch KP; Casas M; Ribasés M; Bosch R; Sánchez-Mora C; Gómez-Barros N; Fernàndez-Castillo N; Bayés M; Halmøy A; Halleland H; Landaas ET; Fasmer OB; Knappskog PM; Heister AJ; Kiemeney LA; Kooij JJ; Boonstra AM; Kan CC; Asherson P; Faraone SV; Buitelaar JK; Haavik J; Cormand B; Ramos-Quiroga JA; Reif A
    Neuropsychopharmacology; 2010 Feb; 35(3):656-64. PubMed ID: 19890261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratask Variability As a Correlate for DRD4 and SLC6A3 Variants: A Pilot Study in ADHD.
    Henríquez-Henríquez M; Villarroel L; Henríquez H; Zamorano F; Rothhammer F; Aboitiz F
    J Atten Disord; 2015 Nov; 19(11):987-96. PubMed ID: 22930791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.
    Albrecht B; Brandeis D; Uebel-von Sandersleben H; Valko L; Heinrich H; Xu X; Drechsler R; Heise A; Kuntsi J; Müller UC; Asherson P; Steinhausen HC; Rothenberger A; Banaschewski T
    J Child Psychol Psychiatry; 2014 Aug; 55(8):914-23. PubMed ID: 24521003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
    Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):412-8. PubMed ID: 12947560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study.
    Smith KM; Daly M; Fischer M; Yiannoutsos CT; Bauer L; Barkley R; Navia BA
    Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):77-85. PubMed ID: 12707943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine.
    Aarts E; van Holstein M; Hoogman M; Onnink M; Kan C; Franke B; Buitelaar J; Cools R
    Behav Pharmacol; 2015 Feb; 26(1-2):227-40. PubMed ID: 25485641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder.
    Yang B; Chan RC; Jing J; Li T; Sham P; Chen RY
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):541-50. PubMed ID: 17440978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
    Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
    Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).
    Feng Y; Wigg KG; Makkar R; Ickowicz A; Pathare T; Tannock R; Roberts W; Malone M; Kennedy JL; Schachar R; Barr CL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):1-6. PubMed ID: 16082693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of intron 8 and 3' UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants.
    Hill M; Anney RJ; Gill M; Hawi Z
    Pharmacogenomics J; 2010 Oct; 10(5):442-7. PubMed ID: 20029387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder.
    Xu X; Mill J; Sun B; Chen CK; Huang YS; Wu YY; Asherson P
    BMC Psychiatry; 2009 Feb; 9():3. PubMed ID: 19196467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes.
    Ettinger U; Joober R; DE Guzman R; O'driscoll GA
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):764-7. PubMed ID: 17109713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children.
    Cheuk DK; Li SY; Wong V
    Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):123-5. PubMed ID: 16402340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample.
    Krämer UM; Rojo N; Schüle R; Cunillera T; Schöls L; Marco-Pallarés J; Cucurell D; Camara E; Rodriguez-Fornells A; Münte TF
    BMC Neurosci; 2009 Dec; 10():150. PubMed ID: 20021692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.
    Bédard AC; Schulz KP; Cook EH; Fan J; Clerkin SM; Ivanov I; Halperin JM; Newcorn JH
    Neuroimage; 2010 Nov; 53(3):935-42. PubMed ID: 20026227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control.
    Heinzel S; Dresler T; Baehne CG; Heine M; Boreatti-Hümmer A; Jacob CP; Renner TJ; Reif A; Lesch KP; Fallgatter AJ; Ehlis AC
    Cereb Cortex; 2013 Jun; 23(6):1453-62. PubMed ID: 22617852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).
    Fallgatter AJ; Ehlis AC; Dresler T; Reif A; Jacob CP; Arcos-Burgos M; Muenke M; Lesch KP
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):458-68. PubMed ID: 23245769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.